Denise Scots-Knight insider trades: Mereo BioPharma Group (MREO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Denise reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | MREO | ↓ Sell | 88,657 | $4.30 | $381K | Direct | Sep 16, 2024 (3d) |
| Jun 26, 2024 | MREO | ↓ Sell | 132,985 | $3.49 | $463K | Direct | Jun 27, 2024 (1d) |
| Dec 31, 2014 | OMED | ↓ Sell | 3,799 | $21.66 | $82K | Indirect | Jan 2, 2015 (2d) |
| Dec 30, 2014 | OMED | ↓ Sell | 17,607 | $21.63 | $381K | Indirect | Dec 30, 2014 (0d) |
| Dec 19, 2014 | OMED | ↓ Sell | 20,654 | $21.71 | $448K | Indirect | Dec 23, 2014 (4d) |
| Dec 10, 2014 | OMED | ↓ Sell | 32,940 | $21.78 | $717K | Indirect | Dec 10, 2014 (0d) |
| Dec 5, 2014 | OMED | ↓ Sell | 25,000 | $21.60 | $540K | Indirect | Dec 5, 2014 (0d) |
| Jun 30, 2014 | OMED | ↓ Sell | 11,485 | $23.59 | $271K | Indirect | Jul 2, 2014 (2d) |
| Jun 25, 2014 | OMED | ↓ Sell | 3,252 | $23.56 | $77K | Indirect | Jun 27, 2014 (2d) |
| Jun 24, 2014 | OMED | ↓ Sell | 64,561 | $24.08 | $1.6M | Indirect | Jun 25, 2014 (1d) |
| Jul 23, 2013 | OMED | ↑ Buy | 58,824 | $17.00 | $1.0M | Indirect | Jul 23, 2013 (0d) |
| Nov 14, 2005 | IDIX | ↓ Sell | 629,498 | $20.61 | $13.0M | By Nomura International plc | Nov 16, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Denise Scots-Knight's insider trades
Denise Scots-Knight is Chief Executive Officer at Mereo BioPharma Group (MREO). Since Nov 14, 2005, Denise has reported 1 open-market purchase worth $1.0M and 11 sales worth $17.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (31 filings), option exercises (2 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MREO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.